Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA Gilead has announced that it has received the approval for Jyseleca (filgotinib) from the regulatory authorities in the European Union an...
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit The Global Vaccine Summit hosted in the UK was successful in raising US$ 8.8 billion, more than the expected target of US$ 7.4 billion. T...
